Table 2.
Timing After Exposure | Laboratory Testing |
Comment | ||
---|---|---|---|---|
HCV EIA | HCV RNA | ALT | ||
Source patient Immediate | Yes | If HCV EIA positive: Yes If HCV EIA negative: Recommend only if source is at risk for false-negative test |
No | Although HCV RNA testing is not routinely recommended, it may be useful in immunocompromised source patients who may have false-negative serology. |
Healthcare worker (if source patient has evidence of HCV infection) | ||||
Immediate | Yes | If HCV EIA positive: Yes | Yes | Healthcare worker does not require follow-up if source patient is HCV negative; however, baseline testing of HCW is prudent. |
4–6 wk | Yes | Yes | Consider | If earlier diagnosis of HCV infection is desired, testing for HCV RNA may be performed to help guide treatment decision making. Due to the intermittent nature of HCV viremia in acute HCV infection, RNA testing should not be the sole screening test. |
4–6 mo | Yes | Yes | Yes | HCV antibody testing 4–6 mo postexposure is considered the optimal means of detecting infection, although seronegative infections have been reported. |
Abbreviations: ALT, alanine aminotransferase; EIA, enzyme immunoassay; HCV, hepatitis C virus; HCW, healthcare worker; RNA, ribonucleic acid.